AM Pharma Investors

69 investors on Angel Roster list AM Pharma in their portfolio. Most are private equity firms and venture capital firms, the most common stage is Seed and the largest groups are based in France, the Netherlands and Spain.

Investors are matched on the company name in their portfolio, so companies that share the name AM Pharma can appear together.

Investors listed
69
With verified email
22%
Most common stage
Seed
Top location
France

Updated October 13, 2026 · How we compile this data

Top 40 AM Pharma investors

The most complete profiles first. Showing 40 of 69.

  • Antoine BoulangerVerified

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • Cristina GarmendiaVerified

    Venture Capital · Spain

    SeedPre-SeedHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: TiGenix, AM Pharma, Ona Therapeutics, STAT-Dx and 27 more

    Verified email available

  • Olivier LitzkaVerified

    Venture Capital, Private Equity Firm, Investor · Germany

    Series BHealth CareWearablesHospitalsWellness

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, Noxxon Pharma and 83 more

    Verified email available

  • Philippe PeltierVerified

    Venture Capital, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: Implanet, AM Pharma, FeetMe, Advanced Perfusion Diagnostics and 36 more

    Verified email available

  • Thierry LaugelVerified

    Venture Capital, Private Equity Firm, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Verified email available

  • Vanessa MalierVerified

    Venture Capital, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Verified email available

  • Anastasia KarpovaVerified

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • Bao DinhVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Boyd RuttenVerified

    Venture Capital, Private Equity Firm · Netherlands

    Health CareWearablesHospitalsWellness

    Portfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more

    Verified email available

  • Christophe SimonVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Eric GallerneVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Henry ZubaidaVerified

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareWearablesHospitalsWellness

    Portfolio: Santaris Pharma, Noema Pharma, AM Pharma, Sapiens Steering Brain Stimulation and 51 more

    Verified email available

  • John MontanaVerified

    Venture Capital, Private Equity Firm, Investment Partner · United Kingdom

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • Luc MaruendaVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Verified email available

  • Matthieu BaretVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Verified email available

  • Nicolas DebockVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Verified email available

  • Nicolas NedelecVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Verified email available

  • Robin RivatonVerified

    Private Equity Firm · France

    Health CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Verified email available

  • Alexandre Foulon

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesHospitalsDeepTech

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more

    Contact details available

  • Amine MAROUF

    Venture Capital, Private Equity Firm, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Annette Fainbloom

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Arnaud Faure

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesHospitalsWellness

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more

    Contact details available

  • Drew Burdon

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Geert

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Hadrien Bouchez

    Venture Capital, Private Equity Firm, Investor · Netherlands

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Holger Reithinger

    Venture Capital, Investor · Germany

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more

    Contact details available

  • Juliette Audet

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Martien van Osch

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more

    Contact details available

  • Martijn Kleijwegt

    Venture Capital, Private Equity Firm, Investor · Netherlands

    Series BHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Matthieu B.

    Venture Capital, Private Equity Firm, Investor · France

    SeedPre-SeedHealth CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Mayeul Caron

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesHospitalsWellness

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more

    Contact details available

  • Nicolas de Loiray

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesE-commercePayments

    Portfolio: AM Pharma, FeetMe, LumApps, Ambler and 80 more

    Contact details available

  • Pierre

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesHospitalsWellness

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more

    Contact details available

  • Rogier Rooswinkel

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Rudy Dekeyser

    Venture Capital, Private Equity Firm, Investor · Belgium

    Series BHealth CareHospitalsLife ScienceMobile

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Sylvain Cascarino

    Venture Capital, Private Equity Firm, Investor · France

    SeedHealth CareHospitalsCRMEducation

    Portfolio: AM Pharma, FeetMe, Advanced Perfusion Diagnostics, Asceneuron and 35 more

    Contact details available

  • Vincent Brichard

    Private Equity Firm, Investor · Netherlands

    SeedHealth CareLife ScienceMobileManufacturing

    Portfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more

    Contact details available

  • Wouter Joustra

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Dominik Escher

    Venture Capital, Investor · Switzerland

    SeedHealth CareLife ScienceBiotechnologyMedical

    Portfolio: AM Pharma, Vico Therapeutics, NovaGo Therapeutics, Corlieve Therapeutics and 5 more

    Contact details available

  • Joël Jean

    Venture Capital

    SeedPre-SeedBiotechnologyElectronic Health Records (EHR)

    Portfolio: Aura Biosciences, Inbiomotion, Cellerix, Ona Therapeutics and 5 more

    Contact details available

See all 69 AM Pharma investors

Search, filter and unlock verified emails and LinkedIn profiles. Free to browse.

Frequently asked questions

How many AM Pharma investors are on Angel Roster?

Angel Roster lists 69 AM Pharma investors. 15 of them (22%) include a verified email address.

What types of investors are they?

The most common investor types are Private Equity Firms (54), Venture Capital Firms (54) and Investment Partner Investors (6). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do AM Pharma investors invest in?

Among those that list a stage, the most common are Seed (18), Series B (10) and Pre-Seed (3).

Where are AM Pharma investors based?

Most are based in France (26), the Netherlands (24) and Spain (5).

Which companies have AM Pharma investors backed?

The most-backed portfolio companies among them are SANIFIT (37), Vico Therapeutics (31), DNA Script (28), Pharvaris (28) and Minoryx Therapeutics (28).

How do I contact AM Pharma investors?

Create a free Angel Roster account to search and filter all 69, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.